Results 111 to 120 of about 13,037,600 (316)

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

open access: yesMolecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham   +21 more
wiley   +1 more source

Conhecimento de escolares acerca de pessoa com deficiência: jogo de labirinto na promoção da saúde [Schoolchildren’s knowledge about disabled people: labyrinth game in health promotion]

open access: yesRevista Enfermagem UERJ, 2015
Estudo transversal, de abordagem quantitativa, que objetivou verificar o conhecimento de escolares antes e após aplicação do jogo de labirinto acerca de pessoa com deficiência.
Jacqueline Mota da Silva   +4 more
doaj  

Edukasi Kualitas Air Minum Yang Aman Bagi Mahasiswa

open access: yesLamahu
The quality of drinking water is a critical factor that impacts an individual's health. Contaminated drinking water can serve as a medium for disease transmission and lead to the decline in organ function. The lack of public awareness about the standards
Rhesti Nurlina Suhanto   +2 more
doaj   +1 more source

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

open access: yesMolecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan   +9 more
wiley   +1 more source

Participação popular no controle da hanseníase: um desafio para o serviço de saúde [Social participation in leprosy control: a challenge for health services]

open access: yesRevista Enfermagem UERJ, 2015
O objetivo do estudo foi analisar, na perspectiva de conselheiros de saúde e líderes comunitários, o processo de intervenção do serviço de saúde no controle da hanseníase.
Fabiana Nascimento Lopes   +1 more
doaj  

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira   +14 more
wiley   +1 more source

Education of Public Health Workers: The Yale Study [PDF]

open access: green, 1955
Edward M. Cohart   +2 more
openalex   +1 more source

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

open access: yesMolecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy   +9 more
wiley   +1 more source

Emerging role of ARHGAP29 in melanoma cell phenotype switching

open access: yesMolecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy